Literature DB >> 20663521

Experimental induction of calcium oxalate nephrolithiasis in mice.

Saeed R Khan1, Patricia A Glenton.   

Abstract

PURPOSE: The availability of various transgenic and knockout mice provides an excellent opportunity to better understand the pathophysiology of calcium oxalate stone disease. However, attempts to produce calcium oxalate nephrolithiasis in mice have not been successful. We hypothesized that calcium oxalate nephrolithiasis in mice requires increasing urine calcium and oxalate excretion, and experimentally induced hyperoxaluria alone is not sufficient. To provide evidence we induced hyperoxaluria by administering hyperoxaluria inducing agents in normocalciuric and hypercalciuric mice, and investigating various aspects of nephrolithiasis.
MATERIALS AND METHODS: We administered ethylene glycol, glyoxylate or hydroxyl proline via diet in male and female normocalciuric B6 mice, and in hypercalciuric sodium phosphate co-transporter type 2 a -/- mice for 4 weeks. We collected 24-hour urine samples on days 0, 3, 7, 14, 21 and 28, and analyzed them for pH, creatinine, lactate dehydrogenase calcium and oxalate. Kidneys were examined using light microscopy. Urine was examined for crystals using light and scanning electron microscopy.
RESULTS: Hypercalciuric mice on hydroxyl proline did not tolerate treatment and were sacrificed before 28 days. All mice on ethylene glycol, glyoxylate or hydroxyl proline became hyperoxaluric and showed calcium oxalate crystalluria. No female, normocalciuric or hypercalciuric mice showed renal calcium oxalate crystal deposits. Calcium oxalate nephrolithiasis developed in all mice on glyoxylate and in some on ethylene glycol. In all mice the kidneys showed epithelial injury. Male mice particularly on glyoxylate had more renal injury and inflammatory cell migration into the interstitium around the crystal deposits.
CONCLUSIONS: Results confirm that hyperoxaluria induction alone is not sufficient to create calcium oxalate nephrolithiasis in mice. Hypercalciuria is also required. Kidneys in male mice are more prone to injury than those in female mice and are susceptible to calcium oxalate crystal deposition. Perhaps epithelial injury promotes crystal retention. Thus, calcium oxalate nephrolithiasis in mice is gender dependent, and requires hypercalciuria and hyperoxaluria. 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20663521      PMCID: PMC3615905          DOI: 10.1016/j.juro.2010.04.065

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  25 in total

Review 1.  The primary hyperoxalurias.

Authors:  M Marangella; M Petrarulo; C Vitale; C Bagnis; S Berutti; A Ramello; A Amoroso
Journal:  Contrib Nephrol       Date:  2001       Impact factor: 1.580

2.  Time trends in reported prevalence of kidney stones in the United States: 1976-1994.

Authors:  Kiriaki K Stamatelou; Mildred E Francis; Camille A Jones; Leroy M Nyberg; Gary C Curhan
Journal:  Kidney Int       Date:  2003-05       Impact factor: 10.612

3.  Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2.

Authors:  Hien Chau; Sherif El-Maadawy; Marc D McKee; Harriet S Tenenhouse
Journal:  J Bone Miner Res       Date:  2003-04       Impact factor: 6.741

4.  Role of sex hormones in experimental calcium oxalate nephrolithiasis.

Authors:  J Fan; P S Chandhoke; S A Grampsas
Journal:  J Am Soc Nephrol       Date:  1999-11       Impact factor: 10.121

5.  Is idiopathic recurrent calcium urolithiasis in males a cellular disease? Laboratory findings in plasma, urine and erythrocytes, emphasizing the absence and presence of stones, oxidative and mineral metabolism: an observational study.

Authors:  Paul Otto Schwille; Mahimaidos Manoharan; Angelika Schmiedl
Journal:  Clin Chem Lab Med       Date:  2005       Impact factor: 3.694

6.  Presence of lipids in urine, crystals and stones: implications for the formation of kidney stones.

Authors:  Saeed R Khan; Patricia A Glenton; Renal Backov; Daniel R Talham
Journal:  Kidney Int       Date:  2002-12       Impact factor: 10.612

7.  Experimental calcium oxalate nephrolithiasis in the rat. Role of the renal papilla.

Authors:  S R Khan; B Finlayson; R L Hackett
Journal:  Am J Pathol       Date:  1982-04       Impact factor: 4.307

8.  A porcine model of calcium oxalate kidney stone disease.

Authors:  Neil S Mandel; James D Henderson; Linda Y Hung; David F Wille; John H Wiessner
Journal:  J Urol       Date:  2004-03       Impact factor: 7.450

9.  Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.

Authors:  Jeffrey A Wesson; Richard J Johnson; Marrilda Mazzali; Anne M Beshensky; Susan Stietz; Ceci Giachelli; Lucy Liaw; Charles E Alpers; William G Couser; Jack G Kleinman; Jeremy Hughes
Journal:  J Am Soc Nephrol       Date:  2003-01       Impact factor: 10.121

10.  Deposition of calcium phosphate and calcium oxalate crystals in the kidneys.

Authors:  S R Khan; P A Glenton
Journal:  J Urol       Date:  1995-03       Impact factor: 7.450

View more
  22 in total

1.  Crystal deposition triggers tubule dilation that accelerates cystogenesis in polycystic kidney disease.

Authors:  Jacob A Torres; Mina Rezaei; Caroline Broderick; Louis Lin; Xiaofang Wang; Bernd Hoppe; Benjamin D Cowley; Vincenzo Savica; Vicente E Torres; Saeed Khan; Ross P Holmes; Michal Mrug; Thomas Weimbs
Journal:  J Clin Invest       Date:  2019-07-30       Impact factor: 14.808

2.  Novel porcine model for calcium oxalate stone formation.

Authors:  Brandon P Trojan; Sara J Trojan; Andrew Navetta; Bryce Staches; Bryan Sutton; Stephanie Filleur; Thomas Nelius
Journal:  Int Urol Nephrol       Date:  2017-07-13       Impact factor: 2.370

3.  Simplified estimates of ion-activity products of calcium oxalate and calcium phosphate in mouse urine.

Authors:  Hans-Göran Tiselius; Renato Ribeiro Nogueira Ferraz; Ita Pfeferman Heilberg
Journal:  Urol Res       Date:  2011-12-27

4.  Osteopontin knockdown in the kidneys of hyperoxaluric rats leads to reduction in renal calcium oxalate crystal deposition.

Authors:  Hidenori Tsuji; Nobutaka Shimizu; Masahiro Nozawa; Tohru Umekawa; Kazuhiro Yoshimura; Marco A De Velasco; Hirotsugu Uemura; Saeed R Khan
Journal:  Urolithiasis       Date:  2014-03-12       Impact factor: 3.436

5.  Hydroxyproline metabolism in mouse models of primary hyperoxaluria.

Authors:  John Knight; Ross P Holmes; Scott D Cramer; Tatsuya Takayama; Eduardo Salido
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-21

6.  Unified theory on the pathogenesis of Randall's plaques and plugs.

Authors:  Saeed R Khan; Benjamin K Canales
Journal:  Urolithiasis       Date:  2014-08-14       Impact factor: 3.436

Review 7.  Experimental models of renal calcium stones in rodents.

Authors:  Héloïse Bilbault; Jean-Philippe Haymann
Journal:  World J Nephrol       Date:  2016-03-06

8.  Calcium oxalate nephrolithiasis and expression of matrix GLA protein in the kidneys.

Authors:  Aslam Khan; Wei Wang; Saeed R Khan
Journal:  World J Urol       Date:  2013-03-09       Impact factor: 4.226

9.  Association study of DGKH gene polymorphisms with calcium oxalate stone in Chinese population.

Authors:  Yong Xu; Guohua Zeng; Zanlin Mai; Lili Ou
Journal:  Urolithiasis       Date:  2014-08-01       Impact factor: 3.436

10.  Hydroxyproline Metabolism and Oxalate Synthesis in Primary Hyperoxaluria.

Authors:  Sonia Fargue; Dawn S Milliner; John Knight; Julie B Olson; W Todd Lowther; Ross P Holmes
Journal:  J Am Soc Nephrol       Date:  2018-03-27       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.